Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Lytras
Editorial: Tofacitinib and Biologics for Moderate-To-Severe Ulcerative Colitis-What Is Best in Class? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Editorial: Tofacitinib and Biologics for Moderate-To-Severe Ulcerative Colitis-What Is Best in Class?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Mesalamine and Mucosal Microbiome in Quiescent Ulcerative Colitis-What Can We Learn? Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy and Safety of Biologic Agents and Tofacitinib in Moderate-To-Severe Ulcerative Colitis: A Systematic Overview of Meta-Analyses
United European Gastroenterology Journal
Oncology
Gastroenterology
Editorial: Faecal Microbiota Transplantation for Ulcerative Colitis-Not Quite There Yet? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Yoga for QoL in Ulcerative Colitis-Any Better Than Other Supportive Activities? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)
Koloproktologia
Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis
Gastroenterology
Hepatology
Gastroenterology
Letter: How to Define Remission in Ulcerative Colitis - Histological Remission Should Be Considered. Authors' Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Do Thiopurines and Biologics Decrease the Risk of Colectomy? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology